LabGenomics Co Ltd is a Korea-based company principally engaged in the provision of in diagnostic and testing services. The Company provides general diagnostic, sample analysis and various genetic molecular diagnostic such as prenatal malformation testing, cancer genetic testing, chromosome abnormality testing and personal genetic testing. The Company also provides in vitro diagnostic products such as deoxyribonucleic acid (DNA) kits, COVID kits, polymerase chain reaction (PCR) kits and others. In addition, the Company provides biosensor for point of care testing (POCT) and healthy food.

Employees

105

Sector

Healthcare Facilities & Services

Calendar

09-23 Significant Split/Dividend

More about the company

Quotes

Date	Price	Change	Volume
26-08-04	₩825.00	+9.85%	8,366,527
26-08-04	₩751.00	+29.93%	4,045,011
26-08-03	₩578.00	+5.67%	300,818
26-07-31	₩547.00	+3.21%	449,367
26-07-30	₩530.00	-5.69%	426,733

End-of-day quote Korea S.E.

More quotes

Income Statement and Estimates

More financial data

Net sales - Rate of surprise

Company calendar

End-of-day quote Korea S.E. Other stock markets 2026-08-05			5-day change	1st Jan Change
825.00 ^KRW	+9.85%		+35.25%	-54.45%

06-14	Daewoong Bio and LabGenomics Collaborate to Introduce Blood-Based Alzheimer?s Disease Diagnostic Technology in Korea	CI
05-19	LabGenomics Co., Ltd. announced that it has received KRW 20 billion in funding	CI

Market Cap	61.25B 43.04M 37.28M 34.75M 31.96M 60.34M 4.09B 61.01M 408M 160M 2.05B 162M 158M 6.78B	P/E 2024	-7.77x	P/E 2025	-2.09x
Enterprise Value	58.73B 41.27M 35.74M 33.32M 30.65M 57.85M 3.92B 58.5M 392M 154M 1.96B 155M 152M 6.5B	EV / Sales 2024	1.68x	EV / Sales 2025	1.5x
Free-Float	83.31%	Yield 2024 *	-	Yield 2025	-

06-14	Daewoong Bio and LabGenomics Collaborate to Introduce Blood-Based Alzheimer?s Disease Diagnostic Technology in Korea	CI
05-19	LabGenomics Co., Ltd. announced that it has received KRW 20 billion in funding	CI
05-11	LabGenomics Co., Ltd. announced that it expects to receive KRW 20 billion in funding	CI
25-06-23	LabGenomics Appoints CEO	MT
23-07-23	LabGenomics USA LLC announced that it has received KRW 75.948 billion in funding from LabGenomics Co., Ltd.	CI
23-07-02	LabGenomics USA LLC announced that it expects to receive KRW 70 billion in funding from LabGenomics Co., Ltd.	CI
23-04-10	Abion Inc. announced that it expects to receive KRW 21 billion in funding from LabGenomics Co., Ltd., Atinum Investment Co., Ltd, NH Investment & Securities Co., Ltd., Investment and others	CI
23-04-09	N Citron, Inc. announced that it has received KRW 1.999999776 billion in funding from LabGenomics Co., Ltd.	CI
23-03-30	N Citron, Inc. announced that it expects to receive KRW 1.999999776 billion in funding from LabGenomics Co., Ltd.	CI
23-01-17	LabGenomics Co., Ltd. announced that it has received KRW 22.71198072 billion in funding	CI
22-08-19	LabGenomics Co., Ltd. announced that it expects to receive KRW 34.09367874 billion in funding	CI
22-08-18	LabGenomics Co., Ltd. announced that it expects to receive KRW 82.71198072 billion in funding from Luha Private Equity and another investor	CI
21-08-27	LabGenomics Co., Ltd.'s Equity Buyback announced on May 28, 2021, has expired.	CI

1 day	+9.85%
1 week	+35.25%
Current month	+50.82%
1 month	+18.36%
3 months	-35.40%
6 months	-53.55%
Current year	-54.45%

LabGenomics Co., Ltd. Stock

Stocks

A084650

KR7084650001

Healthcare Facilities & Services

Valuation: LabGenomics Co., Ltd.

Chart: LabGenomics Co., Ltd.

Latest news : LabGenomics Co., Ltd.

Press Releases: LabGenomics Co., Ltd.

Quotes and Performance

Course Extremes

Managers and Directors: LabGenomics Co., Ltd.

Latest insider transactions

Medical & Diagnostic Laboratories

Financials

Company Profile

Quotes

Income Statement and Estimates

Net sales - Rate of surprise

Manager	Title	Age	Since
Jae-Hak Ryu CEO	Chief Executive Officer	50	2025-06-22
Mi-Seon Moon AUD	Comptroller/Controller/Auditor	42	2026-03-30

Director	Title	Age	Since
Yu-Chan Kim BRD	Director/Board Member	59	2023-03-09
Kyung-Deuk Park BRD	Director/Board Member	42	2024-03-27
Jong-Hoon Lee BRD	Director/Board Member	42	2023-03-09

Date	Insider	Type	Main position	Quantity	% Market Cap.
6/17/24	Jong-Hoon Lee	Buy	Chief Executive Officer	42,000	0.0566%
3/11/24	Gwang-jin Seong	Others		14,104	0.0190%
3/11/24	Gwang-jin Seong	Free		14,104	0.0190%

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
LABGENOMICS CO., LTD.	+9.85%	+35.25%	-65.19%	-81.65%	39.07M
NATERA, INC.	-0.21%	+8.88%	+101.08%	+438.26%	39.41B
LABCORP HOLDINGS INC.	+0.52%	-0.09%	+18.99%	+45.87%	25.27B
SONIC HEALTHCARE LIMITED	+0.72%	+1.09%	-18.62%	-34.75%	7.68B
RADNET, INC.	-3.12%	+6.07%	+20.24%	+101.99%	5.44B
DR. LAL PATHLABS LIMITED	-0.12%	+4.54%	+21.75%	+60.61%	3.32B
GENEDX HOLDINGS CORP.	-1.40%	+12.98%	-35.48%	+879.13%	2.11B
NEOGENOMICS, INC.	-3.44%	+17.39%	+177.43%	-1.19%	2.09B
GUANGZHOU KINGMED DIAGNOSTICS GROUP CO., LTD.	+0.54%	+4.71%	-9.80%	-59.36%	1.9B
DIAN DIAGNOSTICS GROUP CO.,LTD.	+7.57%	+22.14%	+22.67%	-14.98%	1.66B
Average	+1.20%	+13.75%	+23.31%	+133.39%	8.89B
Weighted average by Cap.	+0.29%	+5.92%	+54.16%	+232.08%

	2024	2025
Net sales	85.9B 60.36M 52.28M 48.73M 44.82M 84.62M 5.74B 85.57M 573M 225M 2.87B 227M 222M 9.51B	88.16B 61.95M 53.66M 50.02M 46M 86.85M 5.89B 87.82M 588M 231M 2.95B 233M 228M 9.76B
Net income	-23.8B -16.72M -14.48M -13.5M -12.42M -23.44M -1.59B -23.7M -159M -62.27M -796M -62.81M -61.42M -2.63B	-64.37B -45.24M -39.18M -36.52M -33.59M -63.42M -4.3B -64.12M -429M -168M -2.15B -170M -166M -7.13B
Net Debt	-40.66B -28.57M -24.75M -23.07M -21.22M -40.06M -2.72B -40.5M -271M -106M -1.36B -107M -105M -4.5B	-2.52B -1.77M -1.53M -1.43M -1.31M -2.48M -168M -2.51M -16.8M -6.59M -84.25M -6.65M -6.5M -279M

1 week	500	895
1 month	500	899
Current year	500	1,983
1 year	500	2,585
3 years	500	6,500
5 years	500	7,000
10 years	500	9,633.33